- Home
- RUSHB vs DYN Comparison
RUSHB vs DYN Comparison
Compare RUSHB & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RUSHB
- DYN
- Stock Information
- Founded
- RUSHB 1965
- DYN 1984
- Country
- RUSHB United States
- DYN United States
- Employees
- RUSHB N/A
- DYN N/A
- Industry
- RUSHB Retail-Auto Dealers and Gas Stations
- DYN Medicinal Chemicals and Botanical Products
- Sector
- RUSHB Consumer Discretionary
- DYN Health Care
- Exchange
- RUSHB Nasdaq
- DYN Nasdaq
- Market Cap
- RUSHB 3.7B
- DYN 3.4B
- IPO Year
- RUSHB N/A
- DYN 2020
- Fundamental
- Price
- RUSHB $54.39
- DYN $29.73
- Analyst Decision
- RUSHB
- DYN Strong Buy
- Analyst Count
- RUSHB 0
- DYN 9
- Target Price
- RUSHB N/A
- DYN $52.44
- AVG Volume (30 Days)
- RUSHB 20.8K
- DYN 1.1M
- Earning Date
- RUSHB 10-29-2024
- DYN 11-12-2024
- Dividend Yield
- RUSHB 1.36%
- DYN N/A
- EPS Growth
- RUSHB N/A
- DYN N/A
- EPS
- RUSHB 3.77
- DYN N/A
- Revenue
- RUSHB $7,824,625,000.00
- DYN N/A
- Revenue This Year
- RUSHB N/A
- DYN N/A
- Revenue Next Year
- RUSHB $2.88
- DYN N/A
- P/E Ratio
- RUSHB $14.68
- DYN N/A
- Revenue Growth
- RUSHB 0.59
- DYN N/A
- 52 Week Low
- RUSHB $37.85
- DYN $10.12
- 52 Week High
- RUSHB $58.61
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- RUSHB 58.86
- DYN 46.53
- Support Level
- RUSHB $51.82
- DYN $27.04
- Resistance Level
- RUSHB $57.92
- DYN $35.68
- Average True Range (ATR)
- RUSHB 1.53
- DYN 2.27
- MACD
- RUSHB -0.27
- DYN 0.23
- Stochastic Oscillator
- RUSHB 50.70
- DYN 31.13
About RUSHB Rush Enterprises Inc. Class B
Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States commercial vehicle markets and related aftermarkets.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.